Company Filing History:
Years Active: 2015-2026
Title: Lijuan Yu - Innovator in Hepatitis C Virus Research
Introduction
Lijuan Yu is a notable inventor based in Beijing, China. He has made significant contributions to the field of virology, particularly in the study of the hepatitis C virus (HCV). His innovative work has led to advancements in understanding and producing high-capacity HCV variants.
Latest Patents
Lijuan Yu holds a patent for an invention titled "Infectious hepatitis C virus—high producing HCV variants and use thereof." The objective of this invention is to provide an HCV strain with a high capacity for virus production in a cell culture system. This invention includes a nucleic acid encoding a polyprotein precursor of the hepatitis C virus JFH1 strain, which features one or more amino acid substitutions. Notably, the polyprotein precursor comprises at least a substitution of glutamine at position 862 with arginine, as determined with reference to the amino acid sequence shown in SEQ ID NO: 2 in the Sequence Listing. He has 1 patent to his name.
Career Highlights
Throughout his career, Lijuan Yu has worked with prestigious institutions, including the University of Tokyo and Nihon University. His research has focused on enhancing the understanding of HCV and developing methods for its effective study and treatment.
Collaborations
Lijuan Yu has collaborated with esteemed colleagues in his field, including Yoshihiro Kitamura and Yoko Shimizu. Their combined efforts have contributed to the advancement of research in hepatitis C virus.
Conclusion
Lijuan Yu's innovative work in the field of hepatitis C virus research has made a significant impact on virology. His contributions continue to influence the scientific community and pave the way for future advancements in the treatment of HCV.